Haeyoung Zhang
Gilead Sciences (United States)(US)
Publications by Year
Research Areas
Pharmacogenetics and Drug Metabolism, Neonatal Health and Biochemistry, Advanced Proteomics Techniques and Applications, HIV/AIDS drug development and treatment, Drug Transport and Resistance Mechanisms
Most-Cited Works
- → Age‐ and Genotype‐Dependent Variability in the Protein Abundance and Activity of Six Major Uridine Diphosphate‐Glucuronosyltransferases in Human Liver(2018)112 cited
- → Hepatic Abundance and Activity of Androgen- and Drug-Metabolizing Enzyme UGT2B17 Are Associated with Genotype, Age, and Sex(2018)87 cited
- → Quantitative characterization of UDP-glucuronosyltransferase 2B17 in human liver and intestine and its role in testosterone first-pass metabolism(2018)49 cited
- → Targeted LC-MS/MS Proteomics-Based Strategy To Characterize in Vitro Models Used in Drug Metabolism and Transport Studies(2018)35 cited
- → A study of the pharmacokinetics, safety, and efficacy of bictegravir/emtricitabine/tenofovir alafenamide in virologically suppressed pregnant women with HIV(2023)33 cited
- → Regional Proteomic Quantification of Clinically Relevant Non-Cytochrome P450 Enzymes along the Human Small Intestine(2020)32 cited
- → Normalized Testosterone Glucuronide as a Potential Urinary Biomarker for Highly Variable UGT2B17 in Children 7–18 Years(2020)10 cited
- → Plasma Protein Binding Determination for Unstable Ester Prodrugs: Remdesivir and Tenofovir Alafenamide(2023)7 cited
- → Clinical Pharmacokinetics and Safety of Remdesivir in Phase I Participants with Varying Degrees of Renal Impairment(2024)1 cited
- → An LC-MS/MS proteomics based methodology to simultaneously evaluate the recovery, enrichment and purity of microsomal and cytosolic fractions isolated from tissues for in vitro drug metabolism studies(2018)1 cited